Evaluation of COVID-19 protease and HIV inhibitors interactions

Evaluation of COVID-19 protease and HIV inhibitors interactions

The epidemic of the novel coronavirus disease (COVID-19) that started in 2019 has evoked an urgent demand for finding new potential therapeutic agents. In this study, we performed a molecular docking of anti-HIV drugs to refine HIV protease inhibitors and nucleotide analogues to target COVID-19. The...

Full description

Saved in:

Bibliographic Details
Main Authors:	Tran Linh, Tam Dao Ngoc Hien, Elhadad Heba, Hien Nguyen Minh, Huy Nguyen Tien
Format:	Article
Language:	English
Published:	Sciendo 2022-03-01
Series:	Acta Pharmaceutica
Subjects:	covid-19 sars-cov-2 docking study anti-hiv drugs protease inhibitors
Online Access:	https://doi.org/10.2478/acph-2022-0010
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Promising inhibitors against main protease of SARS CoV-2 from medicinal plants: In silico identification
by: EBENEZER OLUWAKEMI, et al.
Published: (2022-06-01)

Bicyclic peptide-enhanced covalent inhibitor of SARS-CoV-2 3CL protease
by: Qian Wang, et al.
Published: (2024-10-01)

In silico binding role of flavonoids as SARS-CoV-2 main protease (Mpro) inhibitors: A dataset of molecular docking simulation-based high-throughput virtual screening (HTVS)Mendeley Data
by: Mariyam Eema, et al.
Published: (2025-04-01)

Pretreatment with serine protease inhibitors impairs Leishmania amazonensis survival on macrophages
by: Patrícia de Almeida Machado, et al.
Published: (2025-01-01)

Lopinavir and Ritonavir have High Affinity Toward the SARS-CoV-2 S-protein Receptor-binding Domain Sequenced in Brazil
by: Aline Diogo Marinho, et al.
Published: (2025-01-01)

Potato protease inhibitors, a functional food material with antioxidant and anticancer potential
by: Yaotong Liu, et al.
Published: (2023-09-01)

Computer-aided approaches reveal trihydroxychroman and pyrazolone derivatives as potential inhibitors of SARS-CoV-2 virus main protease
by: Atatreh Noor, et al.
Published: (2021-09-01)

Lunasin protease inhibitor concentrate decreases pro-inflammatory cytokines and improves histopathological markers in dextran sodium sulfate-induced ulcerative colitis
by: Andrea Nieto-Veloza, et al.
Published: (2022-11-01)

Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies
by: Daoud Safa, et al.
Published: (2021-06-01)

Identification of promising SARS-CoV-2 main protease inhibitor through molecular docking, dynamics simulation, and ADMET analysis
by: Ganesh Sharma, et al.
Published: (2025-01-01)

Systematic functional analysis and potential application of a serine protease from cold-adapted Planococcus bacterium
by: Weijun Leng, et al.
Published: (2023-09-01)

Efficacy and safety of new protease inhibitor faldaprevir in treatment of hepatitis C
by: M. V. Mayevskaya, et al.
Published: (2013-12-01)

Discovery of the bacterial HslV protease activators as lead molecules with novel mode of action
by: Aurangzeb Sana, et al.
Published: (2025-02-01)

Profiling Pro‐Inflammatory Proteases as Biomolecular Signatures of Material‐Induced Subcutaneous Host Response in Immuno‐Competent Mice
by: Nam M.P. Tran, et al.
Published: (2025-02-01)

Vascular endothelial growth factor A: friend or foe in the pathogenesis of HIV and SARS-CoV-2 infections?
by: Mieke A. van der Mescht, et al.
Published: (2025-02-01)

AXL inhibitors selected by molecular docking: Option for reducing SARS-CoV-2 entry into cells
by: Galindo-Hernández Octavio, et al.
Published: (2022-09-01)

Structural Analysis of Inhibitor Binding to Enterovirus-D68 3C Protease
by: Vincent N. Azzolino, et al.
Published: (2025-01-01)

Production of subtilisin proteases in bacteria and yeast
by: A. S. Rozanov, et al.
Published: (2021-03-01)

Exploring Zinc C295 as a Dual HIV-1 Integrase Inhibitor: From Strand Transfer to 3′-Processing Suppression
by: Sharif Karim Sayyed, et al.
Published: (2024-12-01)

Identifying Allosteric Small-Molecule Binding Sites of Inactive NS2B-NS3 Proteases of Pathogenic <i>Flaviviridae</i>
by: Hovakim Grabski, et al.
Published: (2024-12-01)

Metabolomic Profiling Reveals Potential Biomarkers and Prominent Features in HIV/AIDS Patients Co-Infected with SARS-CoV-2
by: Xuan Yan, et al.
Published: (2025-01-01)

p97 Inhibitors Possessing Antiviral Activity Against SARS-CoV-2 and Low Cytotoxicity
by: Rui Ding, et al.
Published: (2025-01-01)

Zymography of proteases in honey bees (Apis Mellifera) infected with Nosema ceranae
by: Doghuzlu Mohammad Afrasiabi, et al.
Published: (2024-01-01)

Design, synthesis and molecular docking of novel triazole derivatives as potential CoV helicase inhibitors
by: Zaher Nashwa Hafez, et al.
Published: (2020-06-01)

C-28 linker length modulates the activity of second-generation HIV-1 maturation inhibitors
by: K. C. Yuvraj, et al.
Published: (2025-01-01)

Progress on the Classification, Characteristics and Food Industry Application of Microbial Proteases and Lipases
by: Yao ZHANG, et al.
Published: (2025-02-01)

Impact of COVID-19 on Utilization of Healthcare Services Among People Living with HIV (PLHIV): A Systematic Review
by: Enyinnaya Ukaegbu, et al.
Published: (2025-01-01)

Computational and in vitro evaluation of sumac-derived ©Rutan compounds towards Sars-CoV-2 Mpro inhibition
by: Muzaffar Kayumov, et al.
Published: (2025-02-01)

Discovering broad-spectrum inhibitors for SARS-CoV-2 variants: a cheminformatics and biophysical approach targeting the main protease
by: Safar M. Alqahtani
Published: (2025-02-01)

Difference of SARS-CoV-2 infection and influence factors between people with and without HIV infection
by: Jianhui Yang, et al.
Published: (2025-01-01)

Orally administered prednisolone decreases plasma arginine vasopressin and serum copeptin concentrations in healthy dogs
by: Mathieu Victor Paulin, et al.
Published: (2025-01-01)

Engaging the private sector as part of HIV pre-exposure prophylaxis service delivery in Vietnam: a comparative analysis of uptake, persistence and HIV seroconversion from 2018 to 2023
by: Bao Ngoc Vu, et al.
Published: (2025-01-01)

Activity of Various Cathepsin Proteases and Enrichment of Klotho Protein in the Urine and Urinary Extracellular Vesicles After SARS-CoV-2 Infection
by: Niharika Bala, et al.
Published: (2024-12-01)

Evaluation of Growth Performance, Carcass Characteristics, Digestibility and Ileum Histomorphology of Broiler Chickens fed Two Forms of Diets Supplemented with Exogenous Proteases
by: RA Alhotan, et al.
Published: (2025-01-01)

Characteristics and long-term health outcomes of the first domestic COVID-19 outbreak cases in Da Nang, Vietnam: a longitudinal cohort study
by: Miyuki Tsuruoka, et al.
Published: (2025-01-01)

Drug Screening of Flavonoids as Potential VEGF Inhibitors Through Computational Docking and Cell Models
by: Shengying Lin, et al.
Published: (2025-01-01)

Dynamic Multidrug Therapies for HIV: Optimal and STI Control Approaches
by: B. M. Adams, et al.
Published: (2004-06-01)

Exploring the antimicrobial and antioxidative potential of Leucas aspera (Willd.) link: Phytochemical screening, molecular docking, and HR-LC/MS profiling against SARS-CoV-2 protein 3CLPro, Spike and RDB
by: Thavasiaanatham Seenivasan Shalini, et al.
Published: (2025-02-01)

Proposing a new anti-Covid-19 agent by using molecular docking and dynamics simulations
by: Izabella Rodrigues Fonseca da Silva, et al.
Published: (2025-01-01)

Protease-activated receptors in vascular smooth muscle cells: a bridge between thrombo-inflammation and vascular remodelling
by: Anxhela Habibi, et al.
Published: (2025-01-01)